<SEC-DOCUMENT>0000929638-18-000310-index.html : 20180223
<SEC-HEADER>0000929638-18-000310.hdr.sgml : 20180223
<ACCEPTANCE-DATETIME>20180223171709
ACCESSION NUMBER:		0000929638-18-000310
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20180223
DATE AS OF CHANGE:		20180223
GROUP MEMBERS:		CARE CAPITAL INVESTMENTS III LP
GROUP MEMBERS:		CARE CAPITAL OFFSHORE INVESTMENTS III LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-31596
		FILM NUMBER:		18637683

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Care Capital III LLC
		CENTRAL INDEX KEY:			0001599356
		IRS NUMBER:				861148590
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		47 HULFISH STREET
		STREET 2:		SUITE 310
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08542
		BUSINESS PHONE:		609-683-8300

	MAIL ADDRESS:	
		STREET 1:		47 HULFISH STREET
		STREET 2:		SUITE 310
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08542
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>a71441_sc13d.htm
<TEXT>
Document 1 - file: a71441_sc13d.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>exhibit1.htm <DESCRIPTION>JOINT FILING AGREEMENT AS REQUIRED BY RULE 13D-1(K)(1) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED <TEXT> Document 2 - file: exhibit1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2 <SEQUENCE>3 <FILENAME>exhibit2.htm <DESCRIPTION>FORM OF LOCK-UP AGREEMENT <TEXT> Document 3 - file: exhibit2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3 <SEQUENCE>4 <FILENAME>exhibit3.htm <DESCRIPTION>FORM OF SUPPORT AGREEMENT <TEXT> Document 4 - file: exhibit3.htm
</DOCUMENT> </SEC-DOCUMENT>